Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-01-02 @ 1:58 AM
Study NCT ID:
NCT06071767
Status:
RECRUITING
Last Update Posted:
2025-07-02
First Post:
2023-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV-1-infection | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Suppressive Antiretroviral Therapy | View |
| None | HIV | View |
| None | Acute HIV-1 | View |
| None | HIV vaccine | View |
| None | T-cell vaccine | View |
| None | Therapeutic T-cell vaccine | View |
| None | ChAdOx1 | View |
| None | MVA | View |
| None | Conserved region vaccine | View |
| None | HIVconsvX | View |
| None | Toll-like receptor 7 agonist | View |
| None | TLR7 | View |
| None | Broadly neutralizing antibody | View |
| None | Antibodies | View |
| None | HIV antibody | View |
| None | HIV Broadly neutralizing antibody | View |